Cite
Vascular targeted therapy with anti-prostate-specific membrane antigen monoclonal antibody J591 in advanced solid tumors.
MLA
Milowsky, Matthew I., et al. “Vascular Targeted Therapy with Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody J591 in Advanced Solid Tumors.” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, vol. 25, no. 5, Feb. 2007, pp. 540–47. EBSCOhost, https://doi.org/10.1200/JCO.2006.07.8097.
APA
Milowsky, M. I., Nanus, D. M., Kostakoglu, L., Sheehan, C. E., Vallabhajosula, S., Goldsmith, S. J., Ross, J. S., & Bander, N. H. (2007). Vascular targeted therapy with anti-prostate-specific membrane antigen monoclonal antibody J591 in advanced solid tumors. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 25(5), 540–547. https://doi.org/10.1200/JCO.2006.07.8097
Chicago
Milowsky, Matthew I, David M Nanus, Lale Kostakoglu, Christine E Sheehan, Shankar Vallabhajosula, Stanley J Goldsmith, Jeffrey S Ross, and Neil H Bander. 2007. “Vascular Targeted Therapy with Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody J591 in Advanced Solid Tumors.” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 25 (5): 540–47. doi:10.1200/JCO.2006.07.8097.